Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients
NCT ID: NCT02555787
Last Updated: 2024-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4430 participants
OBSERVATIONAL
2015-03-05
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
NCT02558452
A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
NCT02057484
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
NCT01363752
A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
NCT02147938
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
NCT00555789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients converted from tacrolimus BD to Advagraf
Oral
Tacrolimus
oral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tacrolimus
oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma Europe Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Affairs Europe
Role: STUDY_DIRECTOR
Astellas Pharma Europe Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site AU6107
Camperdown, New South Wales, Australia
Site AU6106
Gosford, New South Wales, Australia
Site AU6104
New Lambton, New South Wales, Australia
Site AU6103
Westmead, New South Wales, Australia
Site AU6111
Harvey Bay, Queensland, Australia
Site AU6108
North Adelaide, South Australia, Australia
Site AU6110
Nedlands, Western Australia, Australia
Site AU6105
Perth, Western Australia, Australia
Site AT4301
Graz, Styria, Austria
Site AT4302
Innsbruck, Tyrol, Austria
Site AT4303
Innsbruck, Tyrol, Austria
Site AT4304
Linz, Upper Austria, Austria
Site BE3201
Leuven, Vlaams Brabant, Belgium
Site CA1001
Vancouver, British Columbia, Canada
Site CZ4202
Olomouc, , Czechia
Site FR3310
Nice, Alpes-Maritimes, France
Site FR3318
Strasbourg, Alsace, France
Site FR3324
Lyon, Auvergne-Rhône-Alpes, France
Site FR3315
Marseille, Bouches-du-Rhône, France
Site FR3303
Caen, Calvados, France
Site FR3306
Besançon, Doubs, France
Site FR3311
Brest, Finistère, France
Site FR3302
Bordeaux, Gironde, France
Site FR3313
Toulouse, Haute-Garonne, France
Site FR3307
Rouen, Haute-Normandie, France
Site FR3321
Limoges, Hautte-Vienne, France
Site FR3317
Rennes, Ille-et-Vilaine, France
Site FR3305
Tours, Indre-et-Loire, France
Site FR3312
Nantes, Loire-Atlantique, France
Site FR3314
Angers, Maine-et-Loire, France
Site FR3325
Lille, Nord, France
Site FR3309
Saint-Étienne-de-Montluc, Pays de la Loire Region, France
Site FR3308
Amiens, Picardie, France
Site FR3319
Clermont-Ferrand, Puy-de-Dôme, France
Site FR3322
Poitiers, Vienne, France
Site FR3323
Paris, , France
Site FR3301
Créteil, Île-de-France Region, France
Site FR3316
Le Kremlin-Bicêtre, Île-de-France Region, France
Site DE4902
Mannheim, Baden-Wurttemberg, Germany
Site DE4901
Würzburg, Bavaria, Germany
Site DE4903
Hanover, Lower Saxony, Germany
Site GR3002
Athens, , Greece
Site GR3004
Athens, , Greece
Site HK8201
Hong Kong, , Hong Kong
Site HK8521
Hong Kong, , Hong Kong
Site HU3601
Debrecen, Hajdú-Bihar, Hungary
Site HU3602
Budapest, , Hungary
Site IT3903
Napoli, Campania, Italy
Site IT3907
Verona, Veneto, Italy
Site IT3905
Bari, , Italy
Site IT3902
Bologna, , Italy
Site IT3914
Bolzano, , Italy
Site IT3901
Genova, , Italy
Site IT3904
L’Aquila, , Italy
Site IT3911
Novara, , Italy
Site IT3916
Novara, , Italy
Site IT3910
Padua, , Italy
Site IT3909
Perugia, , Italy
Site IT3912
Salerno, , Italy
Site IT39013
Salerno, , Italy
Site IT3913
Salerno, , Italy
Site IT3908
Sassari, , Italy
Site IT3915
Udine, , Italy
Site IT3906
Venezia, , Italy
Site JP8108
Nagoya, Aiti, Japan
Site JP8109
Toyoake, Aiti, Japan
Site JP8107
Chiba, Chiba, Japan
Site JP8110
Nishinomiya, Hyôgo, Japan
Site JP8111
Nishinomiya, Hyôgo, Japan
Site JP8106
Kawasaki-shi, Kanagawa, Japan
Site JP8105
Ōta-ku, Tôkyô, Japan
Site JP8104
Shinjuku-Ku, Tôkyô, Japan
Site JP8101
Akita, , Japan
Site JP8102
Niigata, , Japan
Site MY6001
Kuala Lumpur, Wilayah Persekutuan Kuala Lump, Malaysia
Site NL3103
Nijmegen, Gelderland, Netherlands
Site NL3104
Amsterdam, North Holland, Netherlands
Site NL3105
Groningen, , Netherlands
Site NL3101
Utrecht, , Netherlands
Site PH6303
Quezon City, National Capital Region, Philippines
Site PL4806
Poznan, Greater Poland Voivodeship, Poland
Site PL4808
Lublin, Lublin Voivodeship, Poland
Site PL4801
Warsaw, Masovian Voivodeship, Poland
Site PL4807
Szczecin, West Pomeranian Voivodeship, Poland
Site PT3511
Porto, , Portugal
Site RO4004
Cluj-Napoca, Cluj, Romania
Site RO4001
Bucharest, , Romania
Site RO4002
Bucharest, , Romania
Site RO4003
Bucharest, , Romania
Site SB3804
Niš, Nišavski Okrug, Serbia
Site SB3801
Belgrade, , Serbia
Site SB3802
Belgrade, , Serbia
Site SB3803
Novi Sad, , Serbia
Site KR8214
Busan, Busan Gwang'yeogsi [Pusan-Kwan, South Korea
Site KR8205
Busan, Busan Gwang'yeogsi [Pusan-Kwan, South Korea
Site KR8203
Pusan, Busan Gwang'yeogsi [Pusan-Kwan, South Korea
Site KR8202
Daegu, Daegu Gwang'yeogsi [Taegu-Kwan, South Korea
Site KR8219
Daegu, Daegu Gwang'yeogsi, South Korea
Site KR8207
Daejeon, Daejeon Gwang'yeogsi [Taejon-K, South Korea
Site KR8212
Gwangju, Gwangju Gwang'yeogsi, South Korea
Site KR8218
Suwon, Gyeonggido [Kyonggi-do], South Korea
Site KR8216
Bucheon-si, Gyeonggido, South Korea
Site KR8201
Incheon, Incheon Gwang'yeogsi [Inch'n-K, South Korea
Site KR8211
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8210
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8206
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8209
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8204
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8208
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8213
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, South Korea
Site KR8215
Ulsan, Ulsan Gwang'yeogsi [Ulsan-Kwan, South Korea
Site ES3410
Santiago de Compostela, A Coruña, Spain
Site ES3401
Barcelona, , Spain
Site ES3403
Barcelona, , Spain
Site TW8862
Kaohsiung City, Kaohsiung, Taiwan
Site TW8863
Taichung, Taichung Municipality, Taiwan
Site TW8861
Tainan City, , Taiwan
Site TH6601
Bangkok, Krung Thep Maha Nakhon [Bangko, Thailand
Site TH6602
Bangkok, Krung Thep Maha Nakhon [Bangko, Thailand
Site TH6603
Khon Kaen, , Thailand
Site GB4403
Peterborough, Cambridgeshire, United Kingdom
Site GB4405
Exeter, Devon, United Kingdom
Site GB4406
Manchester, Lancashire, United Kingdom
Site GB4407
Ipswich, Suffolk, United Kingdom
Site GB4401
Leeds, , United Kingdom
Site GB4402
Liverpool, , United Kingdom
Site GB4408
London, , United Kingdom
Site VN8401
Hà Nội, Ha Noi, Thanh Pho, Vietnam
Site VN8402
Ho Chi Minh City, Ho Chi Minh, Thanh Pho, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
506-MA-1002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.